Core Insights - Optimist Fund reported a return of +9.1% in Q3 2025, outperforming the benchmark return of 7.9% [1] - The fund is focusing on cyclical holdings that have been in multi-year downswings while also paying attention to developments in AI [1] Company Performance: Carvana Co. (NYSE:CVNA) - Carvana Co. experienced a one-month return of -18.80% but saw a 52-week gain of 33.17%, closing at $305.07 per share with a market capitalization of $35.677 billion on October 30, 2025 [2] - The company achieved record highs in key financial metrics, with retail units sold increasing by 41% year over year to 143,280 vehicles and total revenue rising by 42% to $4.84 billion [3] Hedge Fund Interest - Carvana Co. was held by 91 hedge fund portfolios at the end of Q2 2025, an increase from 90 in the previous quarter [4] - Despite the interest, some analysts believe that certain AI stocks present greater upside potential and less downside risk compared to Carvana Co. [4]

Group 1: Hong Kong Stock Market Updates - China Metallurgical Group (01618) saw a decline of over 5%, reporting a revenue of 335.09 billion yuan for the first three quarters, a year-on-year decrease of 18.79%, and a net profit of 3.97 billion yuan, down 41.88% [1] - Fosen Pharmaceutical (01652) surged nearly 74% after announcing that its subsidiary received approval for the "Enzalutamide Soft Capsule" from the National Medical Products Administration of China [1] - Sanhua Intelligent Control (02050) increased over 3%, with a revenue of 24.03 billion yuan for the first three quarters, a year-on-year growth of 16.86%, and a net profit of 3.24 billion yuan, up 40.85% [1] - Rongchang Biopharmaceutical (09995) rose over 5%, reporting a revenue of approximately 1.72 billion yuan, a year-on-year increase of 42.27%, and a net loss of about 551 million yuan, narrowing by 48.6% [1] - New Special Energy (01799) fell nearly 8%, with a revenue of 11.66 billion yuan and a net loss of 526 million yuan for the first three quarters [1] Group 2: Additional Hong Kong Stock Market Updates - Chuny Medical (01858) increased over 10%, reporting a revenue of 756 million yuan, a year-on-year growth of 48.75%, and a net profit of 192 million yuan, up 213.21% [2] - Innovent Biologics (01801) rose over 4%, achieving total product revenue exceeding 3.3 billion yuan in Q3, maintaining a strong year-on-year growth of about 40% [2] - Longpan Technology (02465) increased over 6%, with a revenue of approximately 5.83 billion yuan, a year-on-year growth of 2.91%, and a net loss of about 110 million yuan, narrowing by 63.53% [2] - 3SBio (01530) saw an early morning increase of nearly 7%, following a significant deal with Pfizer worth up to $12.5 billion [2] - China CNR Corporation (01766) fell over 8%, reporting a revenue of approximately 183.87 billion yuan, a year-on-year increase of 20.49%, and a net profit of about 9.96 billion yuan, up 37.53% [2] Group 3: US Stock Market Updates - Carvana (CVNA.US) dropped over 13%, reporting a Q3 revenue growth of 54.5% to $5.65 billion, exceeding analyst expectations [3] - Alphabet (GOOGL.US) rose nearly 2%, with Q3 revenue surpassing $100 billion, driven by strong AI demand boosting cloud business [3] - Meta Platforms (META.US) fell over 11%, reporting Q3 revenue of $51.2 billion, a 26% year-on-year increase, but net profit significantly below expectations due to a one-time tax expense [4] - Bitcoin-related stocks experienced declines, with Strategy (MSTR.US) down nearly 7% and Coinbase (COIN.US) down over 5% [4] - eBay (EBAY.US) plummeted 15%, marking its largest drop in over 20 years despite exceeding sales expectations [4] Group 4: Additional US Stock Market Updates - Comcast (CMCSA.US) fell 4%, losing 104,000 broadband users in Q3, marking the tenth consecutive quarter of user decline [5] - CoreWeave (CRWV.US) dropped over 6% after shareholders rejected a proposed acquisition [5] - Roblox (RBLX.US) fell over 15%, reporting Q3 revenue of $1.4 billion, a 48% year-on-year increase, but widening net losses [5] - Moderna (MRNA.US) rose over 13%, reportedly in talks for a large-scale acquisition with a major pharmaceutical company [6] - Altria (MO.US) fell over 7%, reporting adjusted EPS of $1.45, in line with market consensus, but net revenue declined by 1.7% [6]

Core Viewpoint - Carvana's shares declined by 9.6% following a strong third-quarter earnings report due to disappointing fourth-quarter guidance and rising concerns in the auto industry [1][5][6] Financial Performance - Carvana reported a 44% increase in retail units sold, totaling 155,942, and a 55% rise in revenue to $5.65 billion, surpassing estimates of $5.1 billion [3] - Adjusted EBITDA increased from $429 million to $637 million, with earnings per share rising from $0.64 to $1.03, and adjusted earnings per share reaching $1.50, exceeding the consensus of $1.32 [4] Future Outlook - For the current quarter, Carvana anticipates retail units sold to be 150,000 or more and adjusted EBITDA to exceed the previous range of $2 billion to $2.2 billion, raising concerns about potential sequential declines in vehicle sales [5][8] - Despite strong growth, the stock is considered expensive, with high expectations already factored in [6]

Core Insights - Carvana's stock dropped over 10% to a four-month low of $317.22 following its third-quarter earnings report [1] Financial Performance - The company's total revenue for Q3 increased by 54.5% year-over-year to $5.65 billion, surpassing analyst expectations of $5.08 billion [1] - Earnings per share (EPS) were reported at $1.03, which fell short of the analyst forecast of $1.30 [1] Sales and Projections - Retail sales reached a record high of 156,000 units, reflecting a year-over-year growth of 44% [1] - For Q4, the company anticipates retail sales to exceed 150,000 units and expects adjusted EBITDA for the year to reach or exceed the previously announced upper limit of $2 billion to $2.2 billion [1]

Core Viewpoint - Carvana's stock experienced a significant drop of over 10%, reaching a four-month low of $317.22, despite reporting strong revenue growth in Q3 [1] Financial Performance - The company's Q3 total revenue increased by 54.5% year-over-year to $5.65 billion, surpassing analysts' average expectation of $5.08 billion [1] - Earnings per share (EPS) were reported at $1.03, which fell short of analysts' expectations of $1.30 [1] Sales and Projections - Retail sales reached a record high of 156,000 units, reflecting a year-over-year growth of 44% [1] - For Q4, the company anticipates retail sales to exceed 150,000 units and expects adjusted EBITDA for the year to reach or exceed the upper limit of the previously announced range of $2 billion to $2.2 billion [1]

Core Viewpoint - Carvana's stock experienced a significant drop of nearly 15%, reaching a four-month low of $301.32, despite reporting strong revenue growth in Q3 [1] Financial Performance - Carvana's Q3 overall revenue increased by 54.5% year-over-year to $5.65 billion, surpassing analysts' average expectation of $5.08 billion [1] - The company's earnings per share (EPS) was reported at $1.03, which fell short of analysts' expectations of $1.30 [1] - Retail sales reached a record 156,000 units in Q3, reflecting a year-over-year growth of 44% [1] Future Outlook - Carvana anticipates retail sales in Q4 to exceed 150,000 units [1] - The company expects its full-year adjusted EBITDA to reach or exceed the upper limit of the previously announced range of $2 billion to $2.2 billion [1]

Group 1 - US stock index futures experienced slight declines, with Nasdaq futures down 0.35%, S&P 500 futures down 0.24%, and Dow futures down 0.33% [1] - Major European indices collectively fell, with Germany's DAX down 0.15%, UK's FTSE 100 down 0.61%, France's CAC down 0.91%, and the Euro Stoxx 50 down 0.52% [1] - OpenAI is reportedly planning to apply for an IPO as early as 2026, with a potential valuation of up to $1 trillion [1] - Alphabet, Google's parent company, reported record Q3 revenue of $102.3 billion, with a 34% year-over-year increase in cloud computing revenue [1] - Microsoft reported Q1 FY2026 revenue of $77.67 billion and earnings per share of $3.72, both exceeding expectations; however, Azure and other cloud revenue fell short of buyer expectations [1] - Meta's Q3 revenue was $51.2 billion, with net profit declining to $2.7 billion due to one-time tax expenses; the company raised its full-year capital expenditure guidance [1] Group 2 - Eli Lilly reported a 54% year-over-year revenue increase to $17.6 billion in Q3, raising its full-year revenue forecast [2] - Merck's Q3 sales reached $17.28 billion, with adjusted earnings per share of $2.58, both exceeding expectations [2] - Stellantis reported a 13% year-over-year revenue increase to €37.2 billion in Q3, noting that US tariffs have caused approximately €1 billion in losses this year [2] - Shell's Q3 adjusted profit was $5.43 billion, surpassing expectations; the company announced a $3.5 billion stock buyback plan [2] - ServiceNow reported Q3 revenue of $3.41 billion, with adjusted earnings per share of $4.82, both exceeding expectations; the company plans a 1-for-5 stock split [2] - eBay's Q3 sales grew 9% year-over-year to $2.82 billion, with adjusted earnings per share of $1.36, exceeding expectations [2] - Carvana, a US used car retailer, reported a 54.5% year-over-year revenue increase to $5.65 billion in Q3, with earnings per share of $1.03, which fell short of analyst expectations [2] - KLA Corporation, a semiconductor testing equipment manufacturer, reported a 13% year-over-year revenue increase to $3.21 billion in Q1 FY2026, with adjusted earnings per share of $8.81, exceeding expectations [2] - Novo Nordisk is reportedly increasing its bid for Metsera, while Pfizer's $4.9 billion acquisition may face uncertainties [2] Group 3 - S&P has downgraded Strategy's credit rating to junk status at B-, citing significant "currency mismatch" risks [3]

U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Thursday.Shares of Meta Platforms, Inc. (NASDAQ:META) fell sharply in pre-market trading following third-quarter results.Meta posted upbeat earnings for the third quarter on Wednesday. The company said it sees fourth-quarter revenue in a range of $56 billion to $59 billion, versus the $57.21 billion analyst estimate. Meta also increased its FY25 capital expenditure guidance.Meta Platforms shares dipped 8.5% to $ ...

Core Insights - Carvana's stock dropped over 9.8% in after-hours trading, closing at $319 [1] - The company reported a 54.5% year-over-year revenue increase to $5.65 billion, exceeding analyst expectations of $5.08 billion [1] - Earnings per share were $1.03, which fell short of the analyst forecast of $1.30 [1] - Retail sales reached a record 156,000 units, marking a 44% year-over-year growth [1] - For the fourth quarter, Carvana anticipates retail sales to exceed 150,000 units and expects adjusted EBITDA for the year to reach or exceed the upper limit of the previously announced range of $2 billion to $2.2 billion [1]

分组1 - The Federal Reserve cut interest rates by a quarter point to a new range of 3.75% to 4% as expected, but Chair Jerome Powell indicated a neutral stance on future cuts, disappointing market expectations for a December rate cut [4][5][14] - The market's expectation for a December rate cut decreased from 84% to around 67% following Powell's comments, while the probability for a January cut increased from 42% to 80% [5][14] - Economic indicators show reasonably strong growth, a booming stock market, and stable job market conditions, leading the Fed to consider a cautious approach to further rate cuts [6][9][15] 分组2 - Retailers in the U.S. are ordering less product upfront due to uncertainty surrounding tariffs, indicating a cautious approach in the retail sector [2] - Companies like MGM and eBay reported mixed earnings results, with MGM missing estimates and eBay cutting Q4 earnings forecasts despite beating EPS and revenue expectations [2] - Nvidia achieved a historic milestone by becoming the first company to reach a $5 trillion valuation, reflecting strong performance in the tech sector [1]